Real world treatment patterns of first-line combination therapies among patients with metastatic melanoma and BRAF mutation.

Ying Qiu,Zhiyi Li,Jackson Tang,Pavel Atanasov,Syed Mahmood,Kris Grzegorzewski,Lei Chen,Joyce S Chen

Real world treatment patterns of first-line combination therapies among patients with metastatic melanoma and BRAF mutation.

2017

Ying Qiu
Zhiyi Li
Jackson Tang
Pavel Atanasov
Syed Mahmood
Kris Grzegorzewski
Lei Chen
Joyce S Chen

e21011Background: First line (1L) systemic combination (combo) therapies for treatment of metastatic melanoma (MM) include targeted combo therapies such as dabrafenib+trametinib (D+T) or vemurafeni...

Keywords:

Melanoma
Pathology
Medicine
Mutation
Dabrafenib
metastatic melanoma
Trametinib
Oncology
first line
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations